Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127718701 | 12771870 | 1 | I | 2016 | 20160603 | 20160922 | 20160922 | EXP | US-UCBSA-2016021311 | UCB | 0.00 | F | Y | 73.00000 | KG | 20160922 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127718701 | 12771870 | 1 | PS | KEPPRA | LEVETIRACETAM | 1 | UNK | 21035 | FILM-COATED TABLET | ||||||||||
| 127718701 | 12771870 | 2 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | 250 MG, 2X/DAY (BID) | 21035 | 250 | MG | FILM-COATED TABLET | BID | ||||||
| 127718701 | 12771870 | 3 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | 250 MG, ONCE EVERY NIGHT | 21035 | 250 | MG | FILM-COATED TABLET | QD | ||||||
| 127718701 | 12771870 | 4 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | 500 MG, ONCE EVERY NIGHT | 21035 | 500 | MG | FILM-COATED TABLET | QD | ||||||
| 127718701 | 12771870 | 5 | SS | KEPPRA | LEVETIRACETAM | 1 | Oral | 250 MG, ONCE EVERY NIGHT | 21035 | 250 | MG | FILM-COATED TABLET | QD | ||||||
| 127718701 | 12771870 | 6 | C | LEVOTHROID | LEVOTHYROXINE SODIUM | 1 | Oral | 75 MG, ONCE DAILY (QD) STARTED MANY YEARS AGO | 0 | 75 | MG | QD | |||||||
| 127718701 | 12771870 | 7 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 5 MG, AS NEEDED STARTED 4 TO 5 YEARS AGO | 0 | 5 | MG | ||||||||
| 127718701 | 12771870 | 8 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 5MG BID, + ADD 5 MG FOR BS } 150 | 0 | |||||||||||
| 127718701 | 12771870 | 9 | C | PREDNISONE. | PREDNISONE | 1 | 3 DF, UNK STARTED 6 YEARS AGO | U | U | 0 | 3 | DF | TABLET | ||||||
| 127718701 | 12771870 | 10 | C | Mtx | METHOTREXATE SODIUM | 1 | Oral | 4 DF, ONCE A WEEK STARTED 6 YEARS AGO | 0 | 4 | DF | TABLET | /wk | ||||||
| 127718701 | 12771870 | 11 | C | Mtx | METHOTREXATE SODIUM | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | TABLET | /wk | ||||||
| 127718701 | 12771870 | 12 | C | PROLIA | DENOSUMAB | 1 | UNK, EV 6 MONTHS | 0 | INJECTION | ||||||||||
| 127718701 | 12771870 | 13 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 2000 IU, UNK | U | 0 | 2000 | IU |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127718701 | 12771870 | 1 | Seizure |
| 127718701 | 12771870 | 2 | Syncope |
| 127718701 | 12771870 | 6 | Hypothyroidism |
| 127718701 | 12771870 | 7 | Diabetes mellitus |
| 127718701 | 12771870 | 9 | Rheumatoid arthritis |
| 127718701 | 12771870 | 10 | Rheumatoid arthritis |
| 127718701 | 12771870 | 12 | Osteoporosis |
| 127718701 | 12771870 | 13 | Vitamin D deficiency |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127718701 | 12771870 | HO |
| 127718701 | 12771870 | OT |
| 127718701 | 12771870 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127718701 | 12771870 | Asthenia | |
| 127718701 | 12771870 | Decubitus ulcer | |
| 127718701 | 12771870 | Fall | |
| 127718701 | 12771870 | Sepsis | |
| 127718701 | 12771870 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127718701 | 12771870 | 2 | 20160118 | 201601 | 0 | |
| 127718701 | 12771870 | 3 | 20160121 | 2016 | 0 | |
| 127718701 | 12771870 | 4 | 201605 | 20160528 | 0 | |
| 127718701 | 12771870 | 5 | 20160529 | 0 |